The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117707374 11770737 4 F 2006 20160617 20151123 20160701 EXP CA-VALIDUS PHARMACEUTICALS LLC-CA-2015VAL000731 VALIDUS 0.00 Y 0.00000 20160701 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117707374 11770737 1 PS METOPROLOL TARTRATE. METOPROLOL TARTRATE 1 Oral 50 MG, BID U 17963 50 MG
117707374 11770737 2 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 60 MG, EVERY 4 WEEKS U 0 60 MG
117707374 11770737 3 C NAPROSYN NAPROXEN 1 UNK U 0
117707374 11770737 4 C BETAHISTINE BETAHISTINE 1 12 MG, PRN U 0 12 MG
117707374 11770737 5 C METFORMIN METFORMIN HYDROCHLORIDE 1 UNK U 0
117707374 11770737 6 C GLICLAZIDE GLICLAZIDE 1 UNK U 0
117707374 11770737 7 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117707374 11770737 1 Product used for unknown indication
117707374 11770737 2 Carcinoid tumour of the small bowel
117707374 11770737 3 Product used for unknown indication
117707374 11770737 4 Product used for unknown indication
117707374 11770737 5 Product used for unknown indication
117707374 11770737 6 Product used for unknown indication
117707374 11770737 7 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
117707374 11770737 HO
117707374 11770737 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
117707374 11770737 Abdominal pain
117707374 11770737 Abdominal tenderness
117707374 11770737 Arthralgia
117707374 11770737 Back pain
117707374 11770737 Blood pressure increased
117707374 11770737 Blood pressure systolic increased
117707374 11770737 Cellulitis
117707374 11770737 Cholelithiasis
117707374 11770737 Contusion
117707374 11770737 Diabetes mellitus
117707374 11770737 Diarrhoea
117707374 11770737 Dizziness
117707374 11770737 Fatigue
117707374 11770737 Groin pain
117707374 11770737 Haemoglobin decreased
117707374 11770737 Hepatic pain
117707374 11770737 Hypoaesthesia
117707374 11770737 Injection site erythema
117707374 11770737 Injection site mass
117707374 11770737 Injection site pain
117707374 11770737 Injection site reaction
117707374 11770737 Malaise
117707374 11770737 Malignant neoplasm progression
117707374 11770737 Muscle spasms
117707374 11770737 Muscle tightness
117707374 11770737 Myalgia
117707374 11770737 Nasopharyngitis
117707374 11770737 Nausea
117707374 11770737 Neuralgia
117707374 11770737 Pain
117707374 11770737 Pain in extremity
117707374 11770737 Paraesthesia
117707374 11770737 Peripheral swelling
117707374 11770737 Rash papular
117707374 11770737 Renal impairment
117707374 11770737 Serum serotonin increased
117707374 11770737 Subcutaneous haematoma
117707374 11770737 Urinary tract infection
117707374 11770737 Urine output decreased
117707374 11770737 Vertigo
117707374 11770737 Vomiting
117707374 11770737 White blood cell count increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
117707374 11770737 2 20060530 0